Children’s Hospital Resumes FDA-Funded Study Of PEG 3350 Pediatric Risks
Executive Summary
New FDA assays may show whether polyethylene glycol laxative leaves toxic analytes and metabolites in children with chronic constipation – with potential implications for numerous other products.
You may also be interested in...
FDA Global Supply Chain Concerns Prompt Glycerin DEG Testing Guidance
Pharmaceutical manufacturing facilities and compounding pharmacists should include tests for diethylene glycol content in the identity testing of all lots of glycerin they receive, according to an FDA guidance reflecting growing concern about vulnerabilities in the global supply chain
What The FDA Looks For When Inspecting Sites Soon After Approving Drugs
Quietly issued internal Compliance Program guidance on post-approval inspections suggests official action could be indicated when it turns out some “established conditions” are missing from applications. Whether the rate of these inspections will need to increase in the wake of the pandemic, particularly as applications for complex dosage forms and new manufacturing modalities multiply, remains to be seen.
Reorganization Of US FDA’s Office Of Regulatory Affairs Will Deliver More Preemptive Inspectorate
Top officials plan to coordinate field operations better by creating agencywide IT systems that could prevent quality failures in programs including drugs, not just respond to them. Siloed systems were blamed for missed opportunity to stem infant formula contamination and prevent subsequent shortages.